On the fly News and insights, exclusive to thefly.com

CRON

Cronos Group

$8.85

0.44 (5.23%)

, MO

Altria Group

$44.26

0.75 (1.72%)

04:58
10/18/19
10/18
04:58
10/18/19
04:58

Cronos Group upgraded to Buy from Hold at Stifel

Stifel analyst Andrew Carter upgraded Cronos Group (CRON) to Buy from Hold with a price target of C$14.00, down from C$16.50. The analyst Cronos is "unconstrained" in its ability to invest towards a $200B global opportunity with C$2B in cash on hand the resources of Altria Group (MO), Carter tells investors in a research note titled "Crowning a New King in the North." The analyst believes Cronos will show an "enhanced revenue growth profile" that leverages the distribution capabilities of Altria to build its U.S. CBD business and demonstrate "break-through product potential" in the Canadian vapor segment. Given the company's "advantaged and enhanced position," investors should buy Cronos shares following their recent pullback, says Carter.

CRON

Cronos Group

$8.85

0.44 (5.23%)

MO

Altria Group

$44.26

0.75 (1.72%)

  • 31

    Oct

  • 12

    Nov

  • 12

    Nov

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.